UBAID KHOKHAR: Open Payments
NPI 1275713935 · ORANGE PARK, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 34 payments from 11 companies in 2025. Trend: 2023 $951 · 2024 $1,012 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $193 |
| Axsome Therapeutics, Inc. | 5 | $127 |
| Alkermes, Inc. | 4 | $76 |
| Lundbeck LLC | 3 | $72 |
| E.R. Squibb & Sons, L.L.C. | 3 | $62 |
| Bausch Health US, LLC | 3 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $59 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 2 | $38 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: VRAYLAR, Auvelity, REXULTI, ARISTADA, COBENFY, APLENZIN, CAPLYTA, FANAPT.
Industry payments across FL — which companies pay providers there.
